Raf Inhibitors

查看全部
Product Name B-Raf C-Raf Raf Purity
(E/Z)-Locostatin 99.52%
(Z)-GW 5074
2,4,3',4',6'-Penta-O-(3-methylbutanoyl)sucrose
AD57 98.27%
AD57 hydrochloride
AD80 99.88%
AFG210
Agerafenib 99.78%
Agerafenib hydrochloride
Anticancer agent 124
Antiproliferative agent-54
Antitumor agent-60
ARQ-736
ATWLPPRAANLLMAAS
Avutometinib 99.43%
Avutometinib potassium
AZ 628 99.44%
AZ304 99.77%
Azaspirene
B-Raf IN 1 99.94%
B-Raf IN 11 99.46%
B-Raf IN 13
B-Raf IN 14
B-Raf IN 15 98.0%
B-Raf IN 16
B-Raf IN 17
B-Raf IN 18
B-Raf IN 19
B-Raf IN 5
B-Raf IN 6
B-Raf IN 7
B-Raf IN 8
B-Raf IN 9
B-Raf-IN-20
Belvarafenib 98.97%
Belvarafenib TFA
BI-1622 98.02%
BI-882370 98.55%
BI-882370 (Standard)
BJ-2302
BRAF inhibitor 97.49%
BRAF ligand-1
BRAF V600E Recombinant Human Active Protein Kinase
BRAF V600E/CRAF-IN-1
BRAF V600E/CRAF-IN-2
Braftide 99.51%
BRAFV600E-IN-1
BRAFV600E-IN-2
BRAFV600E-IN-3
BRAFV600E/ABL2-IN-1
Brimarafenib 99.35%
C-RAF kinase-IN-1
CCT196969 99.67%
CCT239065
CCT241161 99.77%
CDC20/HSP90-IN-1
Cefotetan 98.52%
CG 858-Neg
Claturafenib 99.95%
COX/5-LO-IN-2
CST905
Cyclorasin 9A5
Cyclorasin 9A5 TFA 99.57%
DDO-6600 98.19%
Debromohymenialdisine
DPQZ
EBI-907
EGFR/BRAF-IN-1
EGFR/BRAFV600E-IN-1
EGFR/BRAFV600E-IN-2
EGFR/BRAFV600E-IN-4
EGFR/BRAFV600E-IN-5
EGFR/BRAFV600E-IN-6
EGFR/BRAFV600E-IN-7
Encorafenib 99.94%
Encorafenib-13C,d3 98.14%
Erufosine
Everafenib
Exarafenib 99.68%
Ferroptosis inducer-3
Flezurafenibum 99.85%
GDC-0879 99.49%
GNE-9815 98.94%
GW 5074 99.13%
HDB-1 98.02%
HG6-64-1 99.32%
I194496 98.52%
IHMT-RAF-128
INU-152
ISIS 5132
ISIS 5132 sodium
ISIS 5132 sodium scrambled negative control
KBU2046 99.52%
KG5 99.79%
Kobe2601 99.66%
KRAS G12D-IN-30 99.38%
KRAS-IN-55
KRAS-IN-58
L-779450 98.24%
Lifirafenib 98.01%
Lifirafenib maleate
LSN3074753
LUT014 97.09%
LY3009120 98.66%
MAPK-IN-2 99.66%
MCP110 99.82%
MEK-IN-10
MEK/RAF-IN-1
MEK1/C-Raf-IN-1
ML786
ML786 dihydrochloride
MO-2097
Mosperafenib 98.29%
MS934 98.48%
Multi-kinase-IN-5
Multi-target kinase-IN-8
Naporafenib 99.92%
Neopterin 99.95%
NEPP11
Norartocarpetin 99.28%
NST-628 99.35%
Pan-RAF kinase inhibitor 1
pan-Raf/RTK inhibitor 1
PF-0419789
PF-04880594
PHI-501
Plixorafenib 99.10%
PLX-4720 99.90%
PLX-4720-d7
PLX7904 98.72%
PLX7922 98.68%
PQ-1
PROTAC B-Raf degrader 1 99.78%
PROTAC BRAF-V600E degrader-1 98.04%
PROTAC BRAF-V600E degrader-2
R18
R18 TFA 99.36%
Raf inhibitor 1 98.03%
Raf inhibitor 1 dihydrochloride 99.29%
Raf inhibitor 2 98.11%
Raf inhibitor 3
RAF mutant-IN-1
RAF-IN-1
RAF-IN-2
RAF-IN-4
Raf1 Mouse Pre-designed siRNA Set A
Raf1 Rat Pre-designed siRNA Set A
RAF1 YDYD Recombinant Human Active Protein Kinase
RAF265 99.80%
RAF709 99.92%
RAS/RAS-RAF-IN-1
Regorafenib mesylate
rel-Lifirafenib
Rineterkib 98.79%
Rineterkib hydrochloride 99.81%
RMC-7977 99.48%
RRD-251 99.87%
SB-590885 99.77%
SB-590885
SB-682330A
SB-699393
SHR902275 99.80%
SJ-C1044 98.63%
SJF-0628 99.90%
SKLB646
Tagarafdeg 99.41%
TAK-632 98.93%
Takeda-6D 99.41%
TAT-Braftide 99.52%
TBAP-001 98.97%
Tovorafenib 99.17%
Uplarafenib 99.63%
VEGFR-2/BRAF-IN-1
VEGFR-2/BRAF-IN-2
Vem-L-Cy5 98.31%
XL-281
ZM 336372 98.03%
Tinlorafenib 98.21%
Locostatin 99.88%
Regorafenib-d3 98.0%
Regorafenib-13C,d3
Regorafenib 99.93%
Regorafenib N-oxide and N-desmethyl (M5)
Regorafenib N-oxide and N-desmethyl (M5)-d3-1
Regorafenib Hydrochloride 99.09%
Regorafenib monohydrate 99.94%
Dabrafenib Mesylate 99.94%
Sorafenib tosylate 99.98%
Sorafenib-d3 tosylate
Sorafenib-d3 98.16%
Sorafenib-13C,d3 98.35%
Sorafenib-d4 99.9%
Sorafenib 99.84%
Vemurafenib-d5
Vemurafenib-d7
Vemurafenib 99.90%
Cucurbitacin IIa 99.90%
Dabrafenib-d9
Dabrafenib 99.94%
Doramapimod 99.93%
Doramapimod hydrochloride 98.29%
Rafoxanide 98.60%

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础